Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Gamma-1b in Idiopathic Pulmonary Fibrosis
NCT00052039Phase 3Terminated
- Sponsor
- InterMune
- Start
- Apr 2002
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon gamma-1b in idiopathic pulmonary fibrosis (IPF), sponsored by InterMune. Started Apr 2002; status: terminated.
02
Drugs
interferon gamma-1b
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT00052039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00052039.